Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
SLN
Fundamentals

Silence Therapeutics Plc

SLN

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

43.26M
▲11.62M▲36.71%
12 Months Change

Assets

202.64M
▲83.19M▲69.64%
12 Months Change

Liabilities

68.61M
▼-28.84M▼-29.60%
12 Months Change

Free Cash Flow

-49.51M
▲7.68M▲13.43%
12 Months Change

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2024-03-13
Form 20-F
ID: 0000950170-24-030519
2023-03-15
Form 20-F
ID: 0000950170-23-007992
2022-03-17
Form 20-F
ID: 0001564590-22-010774
2021-03-30
Form 20-F
ID: 0001564590-21-016738